EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)

EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)
Product Description

After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.

Read more Show less

Les Laboratoires Medis

  • Country/Region:
    Tunisia
  • On CPHI since:
    2018
View company profile
Categories
more categories Show less

Les Laboratoires Medis

  • Country/Region:
    Tunisia
  • On CPHI since:
    2018
View company profile

More Products from Les Laboratoires Medis (2)

  • BORTESOMIB NEAPOLIS (bortezomib)

    Product BORTESOMIB NEAPOLIS (bortezomib)

    Bortezomib NEAPOLIS for Injection is an antineoplastic agent available for intravenous injection (IV) use only.

    Each single dose vial contains 3.5 mg of Bortezomib as a sterile lyophilized powder
  • ENOXA (enoxaparin sodium)

    Product ENOXA (enoxaparin sodium)

    ENOXA is a Low Molecular Weight Heparin, in a prefilled seringe. It is the first product in sales in Tunisia

Les Laboratoires Medis resources (1)